Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Neumora Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 38 | +38 |
| Shares | 0 | 36.4M | +36.4M |
| Value | $0 | $512.0M | +$512.0M |
New holders (38)
Institutions that held Neumora Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (0)
Institutions that held Neumora Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.